Swiss National Bank - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 150 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$282,000
-65.8%
393,085
+7.8%
0.00%
Q4 2021$824,000
-14.9%
364,785
+8.5%
0.00%
-100.0%
Q3 2021$968,000
-20.5%
336,085
+4.5%
0.00%0.0%
Q2 2021$1,218,000
+14.7%
321,485
+2.5%
0.00%0.0%
Q1 2021$1,062,000
+24.8%
313,785
+3.2%
0.00%0.0%
Q4 2020$851,000
+11.5%
304,0850.0%0.00%0.0%
Q3 2020$763,000
-77.7%
304,085
+20.5%
0.00%
-66.7%
Q2 2020$3,426,000
+201.3%
252,285
+68.2%
0.00%
+200.0%
Q1 2020$1,137,000
+21.6%
149,985
+1.4%
0.00%0.0%
Q4 2019$935,000
+65.8%
147,885
+2.9%
0.00%0.0%
Q3 2019$564,000
-15.9%
143,785
+3.8%
0.00%0.0%
Q2 2019$671,000
-40.9%
138,5850.0%0.00%0.0%
Q1 2019$1,135,000
+42.1%
138,585
-4.1%
0.00%0.0%
Q4 2018$799,000
+15.8%
144,485
+85.0%
0.00%0.0%
Q3 2018$690,000
-11.4%
78,1000.0%0.00%0.0%
Q2 2018$779,000
+4.7%
78,1000.0%0.00%0.0%
Q1 2018$744,000
-22.2%
78,100
+21.5%
0.00%0.0%
Q4 2017$956,000
+400.5%
64,300
+273.8%
0.00%0.0%
Q1 2015$191,000
-4.5%
17,2000.0%0.00%0.0%
Q4 2014$200,00017,2000.00%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,121,283$53,979,0004.02%
DAFNA Capital Management LLC 853,538$6,470,0002.70%
Baupost Group 17,527,968$132,862,0001.96%
Nantahala Capital Management 6,559,478$49,721,0001.86%
Novo Holdings A/S 3,393,039$25,719,0001.72%
Abrams Capital Management 5,656,462$42,876,0001.69%
Stanley-Laman Group, Ltd. 319,073$2,419,0000.73%
Integral Health Asset Management, LLC 200,000$1,516,0000.67%
KNOTT DAVID M 135,169$1,025,0000.65%
Leap Investments LP 54,700$415,0000.61%
View complete list of AKEBIA THERAPEUTICS INC shareholders